Literature DB >> 9725967

Treatment of acute anticholinergic poisoning with physostigmine.

K M Beaver1, T J Gavin.   

Abstract

Five cases of acute anticholinergic poisoning presenting to an inner-city emergency department (ED) are discussed. All five patients presented with classic signs and symptoms of anticholinergic toxicity, which included tachycardia, hot, dry and flushed skin, markedly dilated and fixed pupils, and pronounced delirium. The patients were violently agitated, and physical restraint was required. Initial treatment with benzodiazepines did not diminish their combative behavior. Treatment with intravenous physostigmine salicylate resulted in a decrease in agitation within 15 to 20 minutes of therapy. No untoward effects occurred as a result of treatment with physostigmine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725967     DOI: 10.1016/s0735-6757(98)90003-1

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  5 in total

1.  Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors:  Edward R Marcantonio
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

2.  Timing and frequency of physostigmine redosing for antimuscarinic toxicity.

Authors:  Christopher Rosenbaum; Steven B Bird
Journal:  J Med Toxicol       Date:  2010-12

3.  The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.

Authors:  Joseph W Watkins; Evan S Schwarz; Anna M Arroyo-Plasencia; Michael E Mullins
Journal:  J Med Toxicol       Date:  2015-06

Review 4.  Black henbane and its toxicity - a descriptive review.

Authors:  Anahita Alizadeh; Mohammad Moshiri; Javad Alizadeh; Mahdi Balali-Mood
Journal:  Avicenna J Phytomed       Date:  2014-09

5.  Successful Treatment of an Acute High-Dose Clozapine Poisoning without Detoxication.

Authors:  Amjad Daaboul; Daniel Sedding; Sebastian Nuding; Artjom Schott
Journal:  Am J Case Rep       Date:  2021-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.